Genetic Testing

BOSTON — Genetic testing can play a positive role and help improve outcomes in managing immunodeficiencies, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

SAN DIEGO — Genetic evaluation of patients referred to a U.S. glomerular disease center revealed a genetic diagnosis in 35% of cases, informing prognosis and treatment and allowing for family testing, among other benefits.

The use of chatbot tools may be a valuable part of health management strategies to improve access to cancer genetic services, according to study results.

The loss of UBAP1L gene function appears to be associated with nonsyndromic retinal dystrophy, according to research published in JAMA Ophthalmology.

Greater utilization of genetic testing among men could have considerable benefits with regard to detection, risk management and personalized treatment of cancers, according to authors of a review published in JAMA Oncology.

The National Kidney Foundation has released new recommendations for the use of genomics to test for, and diagnose, genetic kidney diseases, according to a press release.

Only a small percentage of men recommended to undergo genetic testing due to personal or family history of cancer actually received it, according to findings published in Journal of the National Comprehensive Cancer Network.

There are more than 450 monogenetic immune deficiencies. While many of these rare conditions have similar hallmarks, it is crucial for clinicians to differentiate between them.

WASHINGTON — Genetic testing can provide answers about children who may have primary immunodeficiencies when antibody and cell testing meet their limits, according to a speaker at the Academy of Allergy, Asthma & Immunology Annual Meeting.